Abstract Background/Aims: Cardiovascular disease (CVD) is increased in chronic kidney
disease (CKD), and contributed to by the CKD-mineral bone disorder (CKD-MBD). CKD …

Chronic kidney disease (CKD) is associated with excess cardiovascular morbidity and
mortality compared to the general population. Hyperphosphataemia, associated with …

Traditional risk factors for atherosclerotic cardiovascular disease (CVD) do not adequately
explain the considerable increase in cardiovascular mortality observed among patients with …

Background Hyperphosphatemia is associated with increased fibroblast growth factor 23
(FGF23), arterial calcification, and cardiovascular mortality. Effects of phosphate-lowering …

Pathogenesis of vascular calcification in chronic kidney disease. Background
Hyperphosphatemia and hypercalcemia are independent risk factors for higher incidence of …

Chronic kidney disease (CKD) is frequently complicated by arterial calcification. The latter is
part of the associated mineral and bone disorder (CKD-MBD). Hypercalcemia and …

Abnormal bone in chronic kidney disease (CKD) may adversely affect vascular calcification
via disordered calcium and phosphate metabolism. In this context, bone health should be …

Background Arterial stiffness and calcification propensity are associated with high
cardiovascular risk and increased mortality in chronic kidney disease (CKD). Both …

Within the normal range, higher serum phosphate concentrations are associated with
cardiovascular events and mortality in individuals with chronic kidney disease (CKD) and in …

Vascular calcification is associated with significant cardiovascular morbidity and mortality in
patients with chronic kidney disease (CKD). Factors unique to patients with CKD, such as …